Exact Sciences Corporation (EXAS): Price and Financial Metrics
Exact Sciences Corporation (EXAS)
Today's Latest Price: $138.59 USD
Updated Jan 27 1:47pm
Add EXAS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 64 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
EXAS Stock Summary
- With a market capitalization of $21,215,805,896, Exact Sciences Corp has a greater market value than 89.75% of US stocks.
- Over the past twelve months, EXAS has reported earnings growth of 179.92%, putting it ahead of 92.18% of US stocks in our set.
- As for revenue growth, note that EXAS's revenue has grown 82.48% over the past 12 months; that beats the revenue growth of 93.53% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Exact Sciences Corp are AKAM, WST, LOGI, HZNP, and CHKP.
- Visit EXAS's SEC page to see the company's official filings. To visit the company's web site, go to www.exactsciences.com.
EXAS Stock Price Chart Interactive Chart >
EXAS Price/Volume Stats
| Current price | $138.59 | 52-week high | $159.54 |
| Prev. close | $141.04 | 52-week low | $35.25 |
| Day low | $131.74 | Volume | 1,552,989 |
| Day high | $140.06 | Avg. volume | 1,943,107 |
| 50-day MA | $132.56 | Dividend yield | N/A |
| 200-day MA | $101.05 | Market Cap | 20.85B |
Exact Sciences Corporation (EXAS) Company Bio
Exact Sciences is a molecular diagnostics company focused on gastrointestinal cancers. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. The company was founded in 1995 and is based in Madison, Wisconsin.
Loading social stream, please wait...